Diacerein improves liver fibrosis, steatosis, and atherosclerosis in ApoE knockout mice
Journal of Molecular Medicine · 2026-12 · 104 (1)
DOI: 10.1007/s00109-026-02653-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Medicine, online erschienen am 11.03.2026. Verfasst von Jie-Eun Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, CHA University Gangnam Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Anthraquinones, Atherosclerosis, Liver Cirrhosis, Apolipoproteins E. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Seoul National University.
Abstract (Originalsprache)
Non-alcoholic fatty liver disease and atherosclerosis may share a common pathogenesis involving chronic IL-1β-induced inflammation. We aimed to evaluate the efficacy of diacerein, an IL-1 pathway inhibitor, in improving liver fibrosis, steatosis, and atherosclerosis in apolipoprotein E-knockout (apoE k/o) mice. ApoE k/o mice fed a high-fat diet (HFD) were divided into three groups based on diacerein dosage. Liver fat accumulation and fibrosis severity were compared across groups, along with changes in the expression of genes related to lipid metabolism and fibrosis. Atherosclerotic burden in the aorta was evaluated via en face analysis, and the related signaling pathway was verified in vitro. Diacerein treatment reduced the amount of collagen fibers and fat accumulation in the liver in a dose-dependent manner as well as fibrosis-related gene expression. Atherosclerotic plaque burden in the aorta showed a decreasing trend with diacerein treatment, accompanied by reduced expression of pro-inflammatory cytokines, including TNF-α. Diacerein treatment ameliorated liver steatosis/fibrosis and showed beneficial effects on atherosclerosis-related mechanisms in HFD-fed apoE k/o mice. Given its dual anti-inflammatory and anti-fibrotic actions, diacerein represents a promising therapeutic candidate for metabolic disorders characterized by chronic inflammation. Key messages We analyzed the effects of diacerein on liver fibrosis, steatosis, and atherosclerosis in apolipoprotein E knockout (apoE k/o) mice. Diacerein reduced fat accumulation in the liver and collagen fibers in the liver. It decreased the expression of genes related to fibrosis and the burden of atherosclerotic plaque in the aorta. The expression of pro-inflammatory cytokines was reduced. Treatment of apoE knockout mice fed an HFD with diacerein effectively ameliorated liver steatosis/fibrosis and atherosclerosis. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, CHA University Gangnam Medical Center, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. leeykyung@snu.ac.kr.
- Department of Tropical Medicine and Parasitology and Institute of Endemic Disease, Seoul National University College of Medicine, Seoul, Republic of Korea. leeykyung@snu.ac.kr.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. shchoimd@gmail.com.
- Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea. shchoimd@gmail.com.
Förderung
- National Research Foundation of Korea
- Seoul National University
Zitieren
APA
Lee, J. E., Jin, I., Lee, J. J., Jung, J., Lee, J. I., Kim, B. R., Oh, T. J., Lee, Y. K., & Choi, S. H. (2026). Diacerein improves liver fibrosis, steatosis, and atherosclerosis in ApoE knockout mice. Journal of Molecular Medicine, 104(1). https://doi.org/10.1007/s00109-026-02653-1
Vancouver
Lee JE, Jin I, Lee JJ, Jung J, Lee JI, Kim BR, et al. Diacerein improves liver fibrosis, steatosis, and atherosclerosis in ApoE knockout mice. Journal of Molecular Medicine. 2026;104(1). doi:10.1007/s00109-026-02653-1
BibTeX
@article{Lee2026,
author = {Lee, Jie-Eun and Jin, Isom and Lee, Jung-Jae and Jung, Jisu and Lee, Jee-In and Kim, Bo-Rahm and Oh, Tae Jung and Lee, Yun Kyung and Choi, Sung Hee},
title = {Diacerein improves liver fibrosis, steatosis, and atherosclerosis in ApoE knockout mice},
journal = {Journal of Molecular Medicine},
year = {2026},
volume = {104},
number = {1},
doi = {10.1007/s00109-026-02653-1}
}
EUVIMED